All news

Arcutis CMO sells $30,047 in shares for taxes

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

Patrick Burnett, EVP and CMO of Arcutis Biotherapeutics, sold 943 shares worth $30,047 to cover tax obligations on vested restricted stock units. The sale comes as shares trade near a 52-week high, up 45% over six months, with InvestingPro flagging the stock as slightly overvalued. Q3 2026 results beat revenue estimates on ZORYVE demand but missed profit forecasts.

Read original source

ARQT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.